1. Which of the following is available as an oral formulation?
A. Tocilizumab
B. Infliximab
C. Tofacitinib
D. Sarilumab
2. Which of the following is indicated for the treatment of rheumatoid arthritis as monotherapy in labeling approved by the Food and Drug Administration?
A. Tocilizumab
B. Infliximab
C. Rituximab
D. Golimumab
3. Which of the following agents is associated with progressive multifocal leukoencephalopathy?
A. Baricitinib
B. Certolizumab
C. Rituximab
D. Abatacept
4. Which of the following warnings is not shared between tofacitinib and baricitinib?
A. Viral reactivation
B. Thrombotic events
C. Malignancies
D. Gastrointestinal perforations
5. Which of the following disease activity indices is supported by the American College of Rheumatology for use in the assessment of patients with RA?
A. DAS28
B. PASI-75
C. CAT
D. MELD
6. Which of the following biologic medications does not have a role in the treatment of moderate-to-severe rheumatoid arthritis according to the 2015 American College of Rheumatology guidelines?
A. Abatacept
B. Anakinra
C. Etanercept
D. Tofacitinib
7. What do the 2015 American College of Rheumatology guidelines conditionally recommend as the best next option in patients with moderate-to-severe rheumatoid arthritis who do not receive an adequate response to at least a 3-month trial of the TNF-alpha inhibitor etanercept?
A. Switch to tofacitinib
B. Switch to adalimumab
C. Switch to abatacept
D. Maintain therapy for at least an additional 3 months
8. Which of the following vaccines may be safely administered to patients taking TNF-alpha inhibitors?
A. Measles, mumps, rubella
B. Varicella
C. Live-attenuated influenza
D. Zoster recombinant, adjuvanted
9. For which of the following agents has a biosimilar that has been approved by the Food and Drug Administration?
A. Abatacept
B. Baricitinib
C. Etanercept
D. Tofacitinib
10. Which of the following counseling points is generally appropriate to suggest regarding administration for subcutaneously administered TNF-alpha inhibitors?
A. Remove from refrigerator and warm to room temperature using warm water
B. Appropriate injection sites include the upper arms and the abdomen
C. If bleeding occurs from the injection, wipe down with an alcohol wipe
D. Unlike needles from other medications, used needles may be disposed of in the trash
Evaluation Questions
11. To what extent did the program meet objective #1?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
12. To what extent did the program meet objective #2?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
13. To what extent did the program meet objective #3?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
14. To what extent did the program meet objective #4?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
15. To what extent did the program meet objective #5?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
16. Rate the effectiveness of how well the program related to your educational needs:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
17. Rate how well the active learning strategies (questions, cases, discussions) were appropriate and effective learning tools:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
18. Rate the quality of the faculty:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
19. Rate the effectiveness and the overall usefulness of the material presented:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
20. Rate the appropriateness of the examination for this activity:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
21. Rate the effectiveness of how well the activity related to your practice needs:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
22. Rate the effectiveness of how well the activity will help you improve patient care:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
23. Will the information presented cause you to change your practice?
A. Yes
B. No
24. Are you committed to making these changes?
A. Yes
B. No
25. As a result of this activity, did you learn something new?
A. Yes
B. No
26. What is your practice setting or area of practice?
A. Community Pharmacy/Independent
B. Community Pharmacy/Chain
C. Hospital/Health Systems
D. Administrative/Pharmacy Director
E. Critical Care Pharmacy
F. Long-term Care
G. Managed Care/PBM
H. Oncology
I. Specialty Pharmacy
J. Industry/Manufacturing
27. How many years have you been in practice?
A. <5
B. 5 – 10
C. 11 – 20
D. >20